Brii Biosciences Limited (2137.HK)

HKD 1.83

(2.81%)

Net Income Summary of Brii Biosciences Limited

Brii Biosciences Limited's latest annual net income in 2023 was -174.82 Million CNY , up 61.37% from previous year.
Brii Biosciences Limited's latest quarterly net income in 2024 Q2 was -140.26 Million CNY , down 0.0% from previous quarter.
Brii Biosciences Limited reported an annual net income of -452.62 Million CNY in 2022, up 89.01% from previous year.
Brii Biosciences Limited reported an annual net income of -4.12 Billion CNY in 2021, down -241.56% from previous year.
Brii Biosciences Limited reported a quarterly net income of -140.26 Million CNY for 2024 Q1, down -1959.33% from previous quarter.
Brii Biosciences Limited reported a quarterly net income of 7.54 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Net Income Chart of Brii Biosciences Limited (2023 - 2019)

Historical Annual Net Income of Brii Biosciences Limited (2023 - 2019)

Year	Net Income	Net Income Growth
2023	-174.82 Million CNY	61.37%
2022	-452.62 Million CNY	89.01%
2021	-4.12 Billion CNY	-241.56%
2020	-1.2 Billion CNY	-133.4%
2019	-516.84 Million CNY	0.0%

Year	Net Income	Net Income Growth
2024 Q2	-140.26 Million CNY	0.0%
2024 Q1	-140.26 Million CNY	-1959.33%
2023 Q4	7.54 Million CNY	0.0%
2023 FY	-174.82 Million CNY	61.37%
2023 Q3	7.54 Million CNY	107.94%
2023 Q2	-94.95 Million CNY	0.0%
2023 Q1	-94.95 Million CNY	-38.9%
2022 Q2	-173.79 Million CNY	0.0%
2022 Q1	-173.79 Million CNY	71.29%
2022 FY	-452.62 Million CNY	89.01%
2022 Q4	-68.36 Million CNY	0.0%
2022 Q3	-68.36 Million CNY	60.66%
2021 Q1	-1.47 Billion CNY	-235.07%
2021 FY	-4.12 Billion CNY	-241.56%
2021 Q3	-605.33 Million CNY	59.0%
2021 Q4	-605.33 Million CNY	0.0%
2021 Q2	-1.47 Billion CNY	0.0%
2020 FY	-1.2 Billion CNY	-133.4%
2020 Q4	-440.68 Million CNY	0.0%
2020 Q3	-440.68 Million CNY	-185.95%
2020 Q2	-154.11 Million CNY	0.0%
2020 Q1	-154.11 Million CNY	0.0%
2019 FY	-516.84 Million CNY	0.0%

Peer Net Income Comparison of Brii Biosciences Limited

Name	Net Income	Net Income Difference
Uni-Bio Science Group Limited	70.87 Million HKD	346.669%
CK Life Sciences Int'l., (Holdings) Inc.	17.25 Million HKD	1113.501%